New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

Kim, K., Ginsberg, H. N., & Choi, S. H. (2022). New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins. Diabetes & Metabolism Journal, 46(4), 517–532. https://doi.org/10.4093/dmj.2022.0198
Authors:
Kyuho Kim
Henry N Ginsberg
Sung Hee Choi
Affiliated Authors:
Henry N Ginsberg
Columbia Affiliation:
Subjects:
Atherosclerosis (MeSH)
Cardiovascular Diseases (MeSH)
Dyslipidemias (MeSH)
Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
Author Keywords:
angiopoietin-like protein 3
apolipoprotein c-iii
apoprotein(a)
cardiovascular diseases
dyslipidemias
lipoprotein(a)
oligonucleotides, antisense
pcsk9 inhibitors
ppar alpha
statins
elink
Publication Type:
Article
Unique ID:
10.4093/dmj.2022.0198
PMID:
35929170
DOI:
10.4093/dmj.2022.0198
Journal:
Diabetes and Metabolism Journal
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: